November 15, 2024

RFK Jr.'s Vision for U.S. Food and Drug System Reform

The FDA's nutrition department has to go: "They're not doing their job. They're not protecting our kids."

Reuters

November 13, 2024

Baltimore Secures $266M in Opioid Case

Reuters

November 05, 2024

Schizophrenia Drug Hits Primary Goal in Phase 3 Trial

Intra-Cellular Therapies' breakthrough oral drug, lumateperone, has shown a remarkable 63% reduction in relapse risk for schizophrenia patients, offering hope for improved management of this pervasive condition.

Reuters

November 04, 2024

FTC Finalizes "Click-to-Cancel" Rule

FTC finalizes rule requiring subscription-based businesses to provide cancellation processes as simple as enrollment methods, effective 180 days after Federal Register publication.

Conexiant

October 29, 2024

FDA Class II Recall: 7,000+ Duloxetine Bottles

Over 7,000 bottles of Duloxetine 20mg are recalled due to impurity levels exceeding FDA interim limits, posing potential health risks.

Conexiant

October 23, 2024

Young Women Boost Cannabis Use, Firms Rethink Strategy

In a groundbreaking shift, young women lead cannabis consumption, prompting companies to revamp products and invest in targeting the female demographic.

Reuters

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant

May 28, 2024

Former Doc Accused of Murder-for-Hire, Sentenced for Distribution

Former doctor sentenced to 90 months in federal prison for illegal opioid distribution and health care fraud.

Conexiant

June 12, 2024

USPSTF Releases Draft Osteoporosis Screening Guidelines

The USPSTF's draft recommendations reaffirm osteoporosis screening for older women, call for more research on screening men, and address health disparities.

Conexiant